Gujarat Pharma Company
- All
- News
- Videos
-
Gujarat High Court Orders Probe Into Bulgarian's Rape Charge Against Pharma Firm Head
- Saturday December 23, 2023
- India News | Press Trust of India
The Gujarat High Court on Friday directed the chief judicial magistrate to pass an order of investigation in a complaint of rape and human trafficking made by a Bulgarian national against the CMD of a leading Indian pharmaceutical company.
- www.ndtv.com
-
2 Dead, 2 Injured In Explosion At Gujarat Pharma Company
- Tuesday February 28, 2023
- India News | Asian News International
Two persons were killed, and two others injured after a sudden explosion in a Pharma company followed by a massive fire in Gujarat's Valsad district on Monday night.
- www.ndtv.com
-
2 Workers Dead, Three Injured In Reactor Blast At Gujarat Pharma Firm
- Saturday February 5, 2022
- Cities | Press Trust of India
Two workers died and three were injured in a blast at a reactor of a pharma company in Ankleshwar town of Gujarat's Bharuch district, police said on Saturday.
- www.ndtv.com
-
Dishman Pharma Surges On Completion Of FDA Inspection of Gujarat Facility
- Monday July 11, 2016
- Business | NDTV Profit Team
Dishman Pharmaceuticals and Chemicals shares gained as much as 9 per cent to touch a day's high of Rs 149 after the company announced that the inspection at its Bavla facility in Gujarat has been successfully completed by US Food and Drug Regulator.
- www.ndtv.com/business
-
SRF Commissions First Phases of Two Manufacturing Facilities
- Friday April 1, 2016
- Business | Press Trust of India
In August last year, the company's board had given approval to establish manufacturing facility for R-134a Pharma Grade chemical at Dahej in Gujarat at an estimated investment of Rs 25 crore.
- www.ndtv.com/business
-
Sun Pharma Falls 3% on Cautious FY16 Outlook
- Monday November 2, 2015
- Business | NDTV
Sun Pharma shares fell over 3 per cent on Monday after India's biggest pharma company said it expects revenues and net profit to be adversely hit in the short term due to supply constraints at its Halol facility in Gujarat and high expenses arising out of Ranbaxy integration as well as remedial actions.
- www.ndtv.com/business
-
Gujarat High Court Orders Probe Into Bulgarian's Rape Charge Against Pharma Firm Head
- Saturday December 23, 2023
- India News | Press Trust of India
The Gujarat High Court on Friday directed the chief judicial magistrate to pass an order of investigation in a complaint of rape and human trafficking made by a Bulgarian national against the CMD of a leading Indian pharmaceutical company.
- www.ndtv.com
-
2 Dead, 2 Injured In Explosion At Gujarat Pharma Company
- Tuesday February 28, 2023
- India News | Asian News International
Two persons were killed, and two others injured after a sudden explosion in a Pharma company followed by a massive fire in Gujarat's Valsad district on Monday night.
- www.ndtv.com
-
2 Workers Dead, Three Injured In Reactor Blast At Gujarat Pharma Firm
- Saturday February 5, 2022
- Cities | Press Trust of India
Two workers died and three were injured in a blast at a reactor of a pharma company in Ankleshwar town of Gujarat's Bharuch district, police said on Saturday.
- www.ndtv.com
-
Dishman Pharma Surges On Completion Of FDA Inspection of Gujarat Facility
- Monday July 11, 2016
- Business | NDTV Profit Team
Dishman Pharmaceuticals and Chemicals shares gained as much as 9 per cent to touch a day's high of Rs 149 after the company announced that the inspection at its Bavla facility in Gujarat has been successfully completed by US Food and Drug Regulator.
- www.ndtv.com/business
-
SRF Commissions First Phases of Two Manufacturing Facilities
- Friday April 1, 2016
- Business | Press Trust of India
In August last year, the company's board had given approval to establish manufacturing facility for R-134a Pharma Grade chemical at Dahej in Gujarat at an estimated investment of Rs 25 crore.
- www.ndtv.com/business
-
Sun Pharma Falls 3% on Cautious FY16 Outlook
- Monday November 2, 2015
- Business | NDTV
Sun Pharma shares fell over 3 per cent on Monday after India's biggest pharma company said it expects revenues and net profit to be adversely hit in the short term due to supply constraints at its Halol facility in Gujarat and high expenses arising out of Ranbaxy integration as well as remedial actions.
- www.ndtv.com/business